Vivek Subbiah: Delighted to host the latest episode of the JAMA Oncology podcast
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“Such a delight to host the latest episode of the JAMA Oncology podcast!
If you’re looking for insightful, cutting-edge discussions, this one’s perfect for your morning drive.
In this episode, I sit down with Dr. Michael Postow, MD From the Memorial Sloan Kettering Cancer Center author of “Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy.”
This is hosted in American Medical Association Ed Hub.
We dive into the groundbreaking use of Nobel Prize-winning immunotherapy drugs in the treatment of melanoma brain metastases—a major advancement in cancer care.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023